CSMFX
Price
$26.32
Change
+$0.25 (+0.96%)
Updated
Jun 12 closing price
Net Assets
4.17B
VEXMX
Price
$181.04
Change
+$0.90 (+0.50%)
Updated
Jun 12 closing price
Net Assets
93.74B
Interact to see
Advertisement

CSMFX vs VEXMX

Header iconCSMFX vs VEXMX Comparison
Open Charts CSMFX vs VEXMXBanner chart's image
CSMFX vs VEXMX Comparison Chart in %
View a ticker or compare two or three
VS
CSMFX vs. VEXMX commentary
Jun 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CSMFX is a Buy and VEXMX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VEXMX has more cash in the bank: 93.7B vs. CSMFX (4.17B). VEXMX pays higher dividends than CSMFX: VEXMX (0.90) vs CSMFX (0.01). CSMFX was incepted earlier than VEXMX: CSMFX (9 years) vs VEXMX (39 years). CSMFX (1.99) is less costly to investors than VEXMX (0.19). CSMFX is a more actively managed with annual turnover of: 57.00 vs. VEXMX (12.00). CSMFX has a lower initial minimum investment than VEXMX: CSMFX (1000) vs VEXMX (3000). VEXMX annual gain was more profitable for investors over the last year : 26.84 vs. CSMFX (14.24). VEXMX return over 5 years is better than : 28.54 vs. CSMFX (1.33).
CSMFXVEXMXCSMFX / VEXMX
Total Expense Ratio1.990.191,047%
Annual Report Gross Expense Ratio1.990.191,047%
Fund Existence9 years39 years-
Gain YTD13.98914.13099%
Front LoadN/AN/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets4.17B93.7B4%
Annual Yield % from dividends0.010.901%
Returns for 1 year14.2426.8453%
Returns for 3 years34.1162.4955%
Returns for 5 years1.3328.545%
Returns for 10 yearsN/A190.09-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
USGO8.050.23
+2.94%
US GoldMining
PAR14.900.28
+1.92%
PAR Technology Corp
SITM729.898.65
+1.20%
SiTime Corp
ETOR38.52-0.51
-1.31%
Etoro Group Ltd
XTLB2.13-0.21
-8.97%
XTL Biopharmaceuticals Ltd